Neuroinflammatory Loop in Schizophrenia, Is There a Relationship with Symptoms or Cognition Decline?
International Journal of Molecular Sciences,
Journal Year:
2025,
Volume and Issue:
26(1), P. 310 - 310
Published: Jan. 1, 2025
Schizophrenia
(SZ),
a
complex
psychiatric
disorder
of
neurodevelopment,
is
characterised
by
range
symptoms,
including
hallucinations,
delusions,
social
isolation
and
cognitive
deterioration.
One
the
hypotheses
that
underlie
SZ
related
to
inflammatory
events
which
could
be
partly
responsible
for
symptoms.
However,
it
unknown
how
molecules
can
contribute
decline
in
SZ.
This
review
summarises
exposes
possible
contribution
imbalance
between
pro-inflammatory
anti-inflammatory
interleukins
like
IL-1beta,
IL-4
TNFalfa
among
others
on
impairment.
We
discuss
this
affects
microglia
astrocytes
inducing
disruption
blood–brain
barrier
(BBB)
SZ,
impact
prefrontal
cortex
or
associative
areas
involved
executive
functions
such
as
planning
working
tasks.
also
highlight
generated
intestinal
microbiota
alterations,
due
dysfunctional
microbial
colonisers
use
some
anti-psychotics,
central
nervous
system.
Finally,
question
arises
whether
modulate
correct
characterises
if
an
immunomodulatory
strategy
incorporated
into
conventional
clinical
treatments,
either
alone
complement,
applied
specific
phases,
prodromal
first-episode
psychosis.
Language: Английский
Urolithin A ameliorates schizophrenia-like behaviors and cognitive impairments in female rats by modulating NLRP3 signaling
International Immunopharmacology,
Journal Year:
2025,
Volume and Issue:
151, P. 114336 - 114336
Published: Feb. 22, 2025
Language: Английский
Unraveling the potential of neuroinflammation and autophagy in schizophrenia
Hongxia Tao,
No information about this author
Cheng‐Xiang Wang,
No information about this author
Chuan Zou
No information about this author
et al.
European Journal of Pharmacology,
Journal Year:
2025,
Volume and Issue:
997, P. 177469 - 177469
Published: March 5, 2025
Language: Английский
Revealing the Oxidative Stress-Related Molecular Characteristics and Potential Therapeutic Targets of Schizophrenia through Integrated Gene Expression Data Analysis
Xiumei Zhu,
No information about this author
Xi Chen,
No information about this author
Huajie Ba
No information about this author
et al.
Molecular Neurobiology,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 11, 2025
Language: Английский
Transcriptional Regulators in the Cerebellum in Chronic Schizophrenia: Novel Possible Targets for Pharmacological Interventions
International Journal of Molecular Sciences,
Journal Year:
2025,
Volume and Issue:
26(8), P. 3653 - 3653
Published: April 12, 2025
Despite
the
emerging
evidence
of
role
transcriptional
regulators
in
schizophrenia
as
key
molecular
effectors
responsible
for
dysregulation
multiple
biological
processes,
limited
information
is
available
brain
areas
that
control
higher
cognitive
functions,
such
cerebellum.
To
identify
transcription
factors
could
a
wide
panel
altered
proteins
cerebellar
cortex
schizophrenia,
we
analyzed
dataset
obtained
using
one-shot
liquid
chromatography–tandem
mass
spectrometry
on
postmortem
human
chronic
(PXD024937
identifier
ProteomeXchange
repository).
Our
analysis
revealed
11
enriched
(SP1,
KLF7,
SP4,
EGR1,
HNF4A,
CTCF,
GABPA,
NRF1,
NFYA,
YY1,
and
MEF2A)
be
controlling
250
proteins.
The
top
three
significantly
were
SP1,
with
largest
number
targets
SP4
which
belong
to
Krüppel
superfamily.
An
enrichment
vesicle-mediated
transport
was
found
MEF2A
targets,
while
pathways
related
signaling,
inflammation/immune
responses,
apoptosis,
energy
SP1
KLF7
targets.
EGR1
RNA
processing,
GABPA
YY1
mainly
involved
organelle
organization
assembly.
This
study
provides
reduced
impact
through
cerebellum
schizophrenia.
These
findings
suggest
this
represent
pharmacological
interventions
Language: Английский
The Role of Neuroglia in the Development and Progression of Schizophrenia
Neha S. Rawani,
No information about this author
Allen W. Chan,
No information about this author
Kathryn G. Todd
No information about this author
et al.
Biomolecules,
Journal Year:
2024,
Volume and Issue:
15(1), P. 10 - 10
Published: Dec. 25, 2024
Schizophrenia
is
a
complex
heterogenous
disorder
thought
to
be
caused
by
interactions
between
genetic
and
environmental
factors.
The
theories
developed
explain
the
etiology
of
schizophrenia
have
focused
largely
on
dysfunction
neurotransmitters
such
as
dopamine,
serotonin
glutamate
with
their
receptors,
although
research
in
past
several
decades
has
indicated
strongly
that
other
factors
are
also
involved
role
neuroglial
cells
psychotic
disorders
including
should
given
more
attention.
Although
glia
were
originally
present
brain
only
support
neurons
physical,
metabolic
nutritional
capacity,
it
become
apparent
these
variety
important
physiological
roles
abnormalities
function
may
make
significant
contributions
symptoms
schizophrenia.
In
paper,
we
review
microglia,
astrocytes
oligodendroglia
aspects
transmitter
dysregulation,
neuro-inflammation,
oxidative
stress,
synaptic
function,
gut
microbiome,
myelination
blood-brain
barrier
appear
affect
cause,
development
treatment
We
crosstalk
oligodendrocytes
effects
antipsychotics
neuroglia.
Problems
associated
studies
specific
biomarkers
for
discussed.
Language: Английский